Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia. - Wikidata - awgldk - TriplyDB

Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia.

Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia.

http://www.wikidata.org/entity/Q43681634

about

NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation Genetically manipulated mouse models of lung disease: potential and pitfalls Female scent signals enhance the resistance of male mice to influenza.Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling Chronic inflammation induces telomere dysfunction and accelerates ageing in mice.An NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among Caucasians Mechanisms of neutrophil accumulation in the lungs against bacteria.CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs.Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.Critical care medicine in AJRCCM 2003.Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003.Nonphagocytic oxidase 1 causes death in lung epithelial cells via a TNF-RI-JNK signaling axis.Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia.Cystic fibrosis: a mucosal immunodeficiency syndrome.The c-Rel subunit of NF-κB regulates epidermal homeostasis and promotes skin fibrosis in mice.Animal models of human pneumonia.Acute lower respiratory tract infection Myeloid cells control termination of lung inflammation through the NF-kappaB pathway.Functions and regulation of NF-kappaB RelA during pneumococcal pneumonia Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia.Neutrophil recruitment to the lungs during bacterial pneumonia.The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury.Review: Toll-like receptors and NOD-like receptors in pulmonary antibacterial immunity.Nuclear factor-κB: a key regulator in health and disease of lungs.Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.NFKB1: a suppressor of inflammation, ageing and cancer.Beta-catenin binds to the downstream region and regulates the expression C-reactive protein gene.Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome.Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice.The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes.Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.Timing of valproic acid in acute lung injury: prevention is the best therapy?Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases.Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance.Endothelial NF-κB Blockade Abrogates ANCA-Induced GN.Competing benefits of tumor necrosis factor-alpha for bacteria and for host defense.Cell signaling underlying the pathophysiology of pneumonia

P2860

Q24801702-4602E47D-1C87-418A-9F7E-233992202ABD Q28388821-D02B254F-77BC-4C3B-935B-DB41E9E38B7E Q30979205-A6B33788-6916-4E08-AD43-CEE5E3ED3CEA Q33655868-31A30677-8599-450A-B7C0-DBF032352F4C Q33877362-999F3345-2325-413F-A663-378026C36380 Q33900405-BE2F0C6C-8A4D-41E5-A54C-36ABBB11DB8F Q34026316-09199437-8CC9-428C-AD9E-340AE7121076 Q34280062-E88BE2B6-CEFC-4F1B-B973-D8F1CA980FBD Q34326006-2E32B8A4-94D3-4A5F-9832-E835807B8361 Q35219857-D72D2613-F790-47DD-B263-2D3A0EA85DED Q35626606-3F0C7C30-0524-48C5-8C7B-B97CA764FAF1 Q35626620-26BBF581-369A-457D-B33B-96F9B4118014 Q35855299-CF0B6F69-02F5-4BB4-B5C4-C441EDFED4AF Q36179571-612DAAD6-AC12-42B0-84FF-B0E6666346B9 Q36623329-7ADA4991-AF5D-4057-A4ED-CCD14A273D38 Q36989123-F993CF35-AB58-4A5C-9223-DC8782E5BE7E Q37046353-299BA041-6BDD-4E65-BEE4-E99051438B51 Q37084070-10F14C83-06B2-43C6-892F-8FCB30584CFA Q37138892-9E6249B6-A8DC-4251-ABE5-C97B9A5F1330 Q37172096-73042A6F-93CC-4619-A9A8-05D66ED389B0 Q37172129-3E13E756-81DE-4754-A22E-35CE2FD8B03C Q37327875-892079BF-4662-4E08-97CE-3982A0BC336C Q37625593-4EF12105-91BF-4A2A-A97E-CC19F92DD300 Q37736941-28482E93-E2B4-4497-98B9-CB852E96F12A Q37904904-F609FAF7-6E75-445F-B738-94BF962BFF2B Q38585515-B7503949-D0CB-4DD6-BC92-F3923CB7D9D9 Q38668336-90EAF287-0383-4ACB-B23A-5F59A20C95CC Q40092823-2C659AAC-7AD9-4FA3-9D91-CDE8E37280CF Q41609633-65DA8499-6ABB-4675-B719-BC7750520E70 Q41809221-25EE3DC1-804F-4D54-9187-AAB5137BDDEE Q41900872-C722BF6D-AD6D-4E0B-A832-AB373FC8D28F Q44909879-CAF7E396-31B7-4B91-8077-016857EDDEA0 Q47359442-AC55B787-562C-49A8-9346-55B8D33F364F Q47756541-C9D3EDFC-E8D1-4521-B784-FC0D0FE57081 Q47995348-03A3393B-70BC-4345-BA3F-F86D7789D7EB Q50902532-8A8B1FD6-25FF-4D0A-ADBA-EC3B43771DEA Q54514118-2900F77B-740A-4F2D-8C6A-9E3DAA0D5E6D Q57374687-3BB840FF-9AEF-416A-A21B-B3B22B1A20F3

P2860

Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia.

http://www.wikidata.org/entity/Q43681634

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@en

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@nl

type

label

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@en

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@nl

prefLabel

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@en

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@nl

P1433

Q43681634-B68FE76E-757E-4E22-8C6A-033716225A52

P1476

Q43681634-577EBF47-DDFE-43B3-998C-BD6EA38FACE8

P2093

Q43681634-9848B0A9-F95E-4C82-B01D-B35F1E4DD6D3

Q43681634-AF7CAD88-FAB3-4CD9-86C5-C6C6481EC891

Q43681634-CB343F09-4993-4A9F-A02B-14DAA6C93C6D

Q43681634-F1D3D8DA-34BA-4285-A7D7-1A5C7EF39560

Q43681634-F778B260-F7CE-4A2F-9222-C3400C405270

P2860

Q43681634-02FF4CF0-298F-4DCB-ABB9-64AE6CC65D59

Q43681634-06C72D93-A554-4392-AB03-82AFD68BB0BE

Q43681634-08863850-DDC4-4FD4-9875-F65176AF50E7

Q43681634-0CD71B91-CEAB-4644-8A7E-9522D9F57D8D

Q43681634-0CF6986A-B6A3-4D76-92C8-51784B05526C

Q43681634-2454F80B-B4A3-4041-931C-5E7E98C3C401

Q43681634-2BBED0C1-1405-4E6A-9445-8D3D3AD00A3E

Q43681634-338DB2C6-2F9E-43F1-88F1-8BD4ED969974

Q43681634-3E1D8EA3-F897-4270-A646-0FE0E816D1F6

Q43681634-4809AC84-329E-4FA3-B61A-2C65F1FF19D3

P304

Q43681634-F0C0F428-B050-42CA-AEEE-57FF70889A24

P31

Q43681634-1C20E91C-27A0-4DC5-8340-44E5AB156D86

P356

Q43681634-0F9C8CBB-AA0D-4CC7-A945-5E548FEE878A

P407

Q43681634-A599BC74-F43A-48A8-9DAE-8D10EA4AC603

P433

Q43681634-346E4BD0-E041-4ACC-A26B-C8D11CD80A6F

P478

Q43681634-9639DCD5-0837-432E-9D74-1D860FAB750D

P50

Q43681634-D8E31F2E-DEEC-4CEA-BDA3-F52BF4608F8B

P577

Q43681634-5EF732F2-5DC0-4AC4-8727-7CFF621F7E0F

P698

Q43681634-D4A94924-B5B5-47CA-A3BB-0D5F1443FDF9

P356

RCCM.200303-412OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Nuclear factor-kappaB p50 limi ...... ng Escherichia coli pneumonia.

@en

P2093

George P Topulos

http://www.w3.org/2001/XMLSchema#string

Henry B Warren

http://www.w3.org/2001/XMLSchema#string

Lester Kobzik

http://www.w3.org/2001/XMLSchema#string

Mariya S Kogan

http://www.w3.org/2001/XMLSchema#string

Michal M Lupa

http://www.w3.org/2001/XMLSchema#string

P2860

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase

NF-kappaB regulation in the immune system

Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein

KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells

Immunological defects in mice with a targeted disruption in Bcl-3

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

Activators and target genes of Rel/NF-kappaB transcription factors

The acute respiratory distress syndrome

Points of control in inflammation

P304

810-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200303-412OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Joseph P Mizgerd

P577

2003-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12857723

http://www.w3.org/2001/XMLSchema#string